Navigation Links
Seno Medical Instruments Names Dr. Thomas Stavros Medical Director
Date:11/19/2013

SAN ANTONIO, Nov. 19, 2013 /PRNewswire/ -- Seno Medical Instruments, Inc., the company pioneering opto-acoustic imaging as a tool to improve the diagnosis of cancer, today announced that Thomas Stavros, MD, FACR, FSRU, FRANZCR, one of the world's leading experts in breast radiology, has been named the company's Medical Director.

"I am excited to join the Seno management team and help the company in its quest to develop and commercialize opto-acoustic imaging, which I believe could become a new standard in cancer diagnosis," said Dr. Stavros. "I've spent my career working to develop safe and effective breast imaging solutions, and I believe opto-acoustic technology has the potential to significantly improve the breast cancer diagnostic and treatment path. The sad reality is that 80% of biopsies ultimately return negative results due to limitations of current imaging modalities. The Imagio system produces some of the most exciting images depicting angiogenesis and oxygen levels within and around suspicious masses that I've seen in my career and could enable us to more precisely diagnose or rule out breast cancer."

The ImagioTM breast imaging system uses a combination of traditional breast ultrasound co-registered with opto-acoustic technology, and provides physicians real time anatomical images of the breast with a functional "blood map" of a potentially suspicious mass.

Dr. Stavros is a practicing women's imaging radiologist with more than 30 years of breast imaging experience, and is currently a women's imaging radiologist at Sutter Medical Group, Sacramento, California. Dr. Stavros has been involved in mammography since 1976 and has been actively involved in the development of high-frequency hand-held breast ultrasound since 1981. He is a reviewer for several medical journals and has written or co-authored numerous articles. Dr. Stavros has also written the textbook Breast Ultrasound, the definitive work on this subject in the United States.

Dr. Stavros lectures about ultrasound, particularly about breast ultrasound, at numerous clinical conferences worldwide and has presented more than 1,800 invited lectures and abstracts.

He is a fellow of the American College of Radiology, a fellow of the Society of Radiologists in Ultrasound, and an honorary fellow of the Royal Australian and New Zealand College of Radiology, where he was the Traveling Baker Professor in 1999. He received his medical degree from the University of Colorado School of Medicine in Denver and bachelor's degree from St. Olaf College in Minnesota.

He has served as a clinical advisor for several ultrasound, breast imaging, and minimally invasive biopsy device companies including General Electric, Phillips and Ethicon Endo-Surgery.

"Dr. Stavros' unprecedented experience in breast imaging using ultrasound makes him an ideal Medical Director for our company. We are proud to have him join our team," said Janet Campbell, CEO, Seno Medical Instruments. "Tom is one of the leading minds in the field driving our clinical development path and helping us in our goal to improve the diagnosis of breast cancer for women around the globe. He brings invaluable clinical experience that will help facilitate development of Imagio and help us bring this important technology to commercialization."

Given the positive outcomes from the Feasibility Study, Seno's management believes that Imagio has the potential to be an important factor in the diagnostic standard of care. The objective is to provide a better tool for the user and a more accurate, efficient, safer and cost effective diagnostic care path.

About SENO Medical Instruments, Inc.

Seno Medical Instruments, Inc. is a San Antonio, Texas-based medical imaging company committed to the development and commercialization of a new standard in cancer diagnosis: opto-acoustic imaging. Seno's Imagio™ breast imaging system uses opto-acoustic technology co-registered with ultrasound to generate functional and anatomical images of the breast. The opto-acoustic images provide a unique blood map around suspicious breast masses while the ultrasound provides a traditional anatomic image. Through the appearance or absence of the two hallmark indicators of cancer – angiogenesis and deoxygenation – Seno believes that Imagio images will be a more effective tool to help radiologists confirm or rule out malignancy than current diagnostic imaging modalities – without exposing patients to potentially harmful ionizing radiation or contrast agents. Seno's platform technology may also address other disease applications. To learn more about Seno Medical's opto-acoustic imaging technology and applications, visit www.SenoMedical.com.


'/>"/>
SOURCE Seno Medical Instruments, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. TriReme Medical and Japanese Partner Century Medical, Inc., Receive Shonin Approval for GliderXtreme PTA Catheter in Japan
2. Noser Engineering AG Expand Medical Device Technology Offering Meeting the Needs of Global Regulatory Compliance and Accelerating Time to Market
3. Regina E. Dugan Appointed to Board of Directors of Varian Medical Systems
4. Emerging Medical Technologies Spotlight - 2012 Includes 1855 Companies and Is Updated Monthly
5. Medical Device Market Opportunities In France, 2012
6. Medical Device Market Opportunities in Germany, 2012
7. Medical Device Market Opportunities in Mexico, 2012
8. Veran Medical Technologies Welcomes New Member to its Board of Directors
9. China Medical Display Industry Report 2013
10. Varian Medical Systems Board of Directors Authorizes Repurchase of Additional 6 Million Shares of Stock through Calendar Year 2014
11. New Factors Reshaping Medical Education Programs in the Life Sciences Industries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... 2017  Lilac Corp, the company that sells ... of a new website . The website ... clinical study that showed surprising clearance of the ... individuals suffering from HPV warts, precancerous, or cancerous ... no other treatments that clear the virus. Specifically, ...
(Date:5/15/2017)... , May 15, 2017  Amy Baxter MD, ... industry leader in noninvasive pain relief, was awarded a ... magazine. Baxter was recognized at the MM&M Top ... New York City on May 10, 2017. ... the biopharma industry go "beyond the pill."  ...
(Date:5/10/2017)... -- Hologic, Inc. (Nasdaq: HOLX ) announced ... quarter ended April 1, 2017 .   GAAP diluted ... to the prior year period as the sale of ... while non-GAAP diluted EPS of $0.50 increased 6.4%.  Revenue ... currency terms.  Excluding the effects of blood screening and ...
Breaking Medicine Technology:
(Date:5/23/2017)... York, N.Y. (PRWEB) , ... May 23, 2017 , ... ... “A Public Health Crisis Worthy of a Policy Response”, -The Rory Staunton Foundation Calls ... Rory Staunton Foundation for the Prevention of Sepsis ( http://www.rorystauntonfoundation.org ) today reported on ...
(Date:5/23/2017)... Beach, CA (PRWEB) , ... May 23, 2017 ... ... Certified Facial Plastic and Reconstructive Surgeon Dr. Kevin Sadati, is pleased to announce ... interested in building collagen and elastin in their face, neck, and body through ...
(Date:5/23/2017)... ... May 23, 2017 , ... Diagnotes, an Indianapolis-based digital healthcare ... on its secure clinical communication platform. The platform allows clinicians to easily escalate ... type and urgency of a situation. , “We know from our daily ...
(Date:5/23/2017)... , ... May 23, 2017 , ... ... receive treatment using the SPEED System™ Orthodontics, with or without a referral, from ... in El Segundo, CA, who is skilled in providing patients with the ...
(Date:5/22/2017)... ... May 22, 2017 , ... Patients who avoid necessary dental and endodontic treatments ... Mt. Kisco, NY from Advanced Endodontics of Westchester. This highly-trained team of endodontists offer ... or more sedation methods may be recommended based on the severity of the anxiety ...
Breaking Medicine News(10 mins):